📰 Precision Flow News
Page 6 - Precision Flow News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Precision Flow. Real-time updates on events, politics, business and more.
April 21, 2022
Vapotherm (NYSE:VAPO – Get Rating) and USA Equities (OTCMKTS:USAQ – Get Rating) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, valuation, analyst recommendations, profitability, risk, earnings and institutional ownership. Profitability This table compares Vapotherm and USA Equities’ net margins, […]
April 13, 2022
Vapotherm (NYSE:VAPO – Get Rating) had its target price reduced by research analysts at Canaccord Genuity Group from $21.00 to $12.00 in a note issued to investors on Wednesday, Benzinga reports. The brokerage presently has a “buy” rating on the stock. Canaccord Genuity Group’s price objective points to a potential upside of 82.37% from the […]
April 13, 2022
Vapotherm (NYSE:VAPO – Get Rating) had its target price cut by stock analysts at Canaccord Genuity Group from $21.00 to $12.00 in a research report issued on Wednesday, The Fly reports. Canaccord Genuity Group’s price objective indicates a potential upside of 92.93% from the company’s current price. VAPO has been the topic of a number […]
April 13, 2022
Canaccord Genuity has decided to maintain its Buy rating of Vapotherm (NYSE:VAPO) and lower its price target from $21.00 to $12.00. Shares of Vapo...
April 7, 2022
Vapotherm (NYSE:VAPO – Get Rating) was downgraded by equities researchers at Piper Sandler from an “overweight” rating to an “underweight” rating in a note issued to investors on Thursday, The Fly reports. A number of other equities research analysts also recently issued reports on VAPO. Canaccord Genuity Group reduced their price target on shares of […]
April 6, 2022
Vapotherm (NYSE:VAPO – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a report released on Wednesday, Zacks.com reports. According to Zacks, “Vapotherm Inc. is a medical technology company. It designs and develops respiratory devices for the treatment of chronic lung and acute breathing disorders. The Company […]
April 6, 2022
Vapotherm, Inc. , today announced preliminary unaudited revenue for the quarter ended March 31, 2022. The Company also announced withdrawal of its full year 2022 revenue guidance together with its... | April 6, 2022
April 1, 2022
Wall Street analysts expect Vapotherm, Inc. (NYSE:VAPO – Get Rating) to report $26.32 million in sales for the current quarter, Zacks Investment Research reports. Two analysts have issued estimates for Vapotherm’s earnings. The lowest sales estimate is $24.80 million and the highest is $27.84 million. Vapotherm reported sales of $32.31 million during the same quarter […]
March 14, 2022
Equities analysts forecast that Vapotherm, Inc. (NYSE:VAPO – Get Rating) will report earnings per share of ($0.65) for the current fiscal quarter, according to Zacks Investment Research. Two analysts have issued estimates for Vapotherm’s earnings, with the lowest EPS estimate coming in at ($0.67) and the highest estimate coming in at ($0.63). Vapotherm posted earnings […]
March 5, 2022
Squarepoint Ops LLC decreased its holdings in Vapotherm, Inc. (NYSE:VAPO – Get Rating) by 22.7% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 25,116 shares of the company’s stock after selling 7,378 shares during the period. Squarepoint Ops LLC owned about 0.10% of […]